Ensysce Biosciences Reports Compliance with Nasdaq Equity Rule and Requests Additional Grace Period

Filing content

The company reported meeting the minimum stockholders' equity requirement for continued Nasdaq listing following recent financing and has requested a second 180-day grace period to regain compliance with the bid price rule.